Zuo Jun Zou
Founder chez BEIJING STRONG BIOTECHNOLOGIES,INC.
Fortune : 105 M $ au 31/03/2024
Profil
Zuo Jun Zou is the Chairman and founder of Beijing Strong Biotechnologies, Inc., which was founded in 2001.
Dr. Zou is also currently serving as the Chairman of Fuzhou Maixin Biotech Co., Ltd.
since 2020.
Dr. Zou obtained a graduate degree from the Chinese Academy of Sciences in 1985, an undergraduate degree from East China University of Science & Technology in 1982, and a doctorate degree from the Research Center For Eco Env Chinese Academy in 1988.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 29 628 625 ( 11,65% ) | 79 M $ | 31/03/2024 | |
| 30/06/2023 | 9 876 208 ( 2,95% ) | 26 M $ | 31/03/2024 |
Postes actifs de Zuo Jun Zou
| Sociétés | Poste | Début |
|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Founder | 29/03/2001 |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Chairman | 05/01/2022 |
Formation de Zuo Jun Zou
| Chinese Academy of Sciences | Graduate Degree |
| East China University of Science & Technology | Undergraduate Degree |
| Research Center For Eco Env Chinese Academy | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
| Beijing Strong Biotechnologies, Inc. |
